| ADMET | Absorption, distribution, metabolism, excretion, and toxicity |
| AMPK | AMP-activated protein kinase |
| ANOVA | Analysis of variance |
| AUC | Area under the curve |
| BBB | Blood–brain barrier |
| CBF | Cerebral blood flow |
| CMC | Carboxymethyl cellulose |
| CNS | Central nervous system |
| CYP | Cytochrome pigment |
| DAPI | 4′,6-Diamidino-2-phenylindole |
| EB | Evans blue |
| eNOS | endothelial NOS |
| FA | Ferulic acid; 4-hydroxy-3-methoxycinnamic acid |
| FAD012 | 3,5-Dimethyl-4-hydroxy cinnamic acid |
| HO-1 | Heme oxygenase-1 |
| i.p. | Intraperitoneal |
| i.v. | Intravenous |
| LD50 | Lethal dose 50 |
| LOAEL | Lowest observed adverse effect level |
| L-NAME | NG-nitro-L-arginine methyl ester |
| MCAO/Re | Middle cerebral artery occlusion following reperfusion |
| MMPs | Matrix metalloproteinases |
| NO | Nitric oxide |
| NOS | NO synthase |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| PI3K | phosphoinositide 3-kinase |
| t-PA | Tissue plasminogen activator |
| TTC | 2,3,5-Triphenyl tetrazolium chloride |
| PBS | Phosphate-buffered saline |
| p-eNOS | phosphorylated eNOS |
| RBMVECs | Rat brain microvascular endothelial cells |
| ROS | Reactive oxygen species |
| TJ | Tight junction |
| vWF | von Willebrand factor |